Charles Flexner

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Diana Finzi, Joel N. Blankson, Janet D. Siliciano et al. · Nature Medicine · 1999 · 2.1K citations

Primary Immunodeficiency, Effective Combination Therapy, Viral Persistence +12

Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

Craig W. Hendrix, Charles Flexner, R. T. MacFarland et al. · Antimicrobial Agents and Chemotherapy · 2000 · 503 citations · Full text

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

Brent G. Petty, David R. Cornblath, Bruce T. Adornato et al. · Annals of Neurology · 1994 · 394 citations

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Craig W. Hendrix, Ann C. Collier, Michael M. Lederman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 362 citations

Cxcr4 Receptor Inhibitor, Medicine, Antiviral Activity +14

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

Alan W. Heldman, Tina V. Hartert, Stuart C. Ray et al. · The American Journal of Medicine · 1996 · 288 citations